Suxibuzone CAS 27470-51-5

27470-51-5 86TDZ5WP2B Suxibuzone Suxibuzone [INN:BAN:JAN] Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester (9CI) 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester) Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) AE-17 Alfide BRN 0904563 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate EINECS 248-477-6 Flogos Solurol Suxibuzona [INN-Spanish] Suxibuzonum [INN-Latin] 4-Hydroxymethylbutazolidine hemisuccinate 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure AE 17 Flamilon Danilon Calibene Aflogan Suxibuzona Suxibuzonum UNII-86TDZ5WP2B

纯度 97%+现货药物标准品
CAS 号27470-51-5
分子式C24H38N2O6
分子量450.57 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

Suxibuzone 27470-51-5 86TDZ5WP2B Suxibuzone Suxibuzone [INN:BAN:JAN] Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester (9CI) 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester) Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) AE-17 Alfide BRN 0904563 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate EINECS 248-477-6 Flogos Solurol Suxibuzona [INN-Spanish] Suxibuzonum [INN-Latin] 4-Hydroxymethylbutazolidine hemisuccinate 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure AE 17 Flamilon Danilon Calibene Aflogan Suxibuzona Suxibuzonum UNII-86TDZ5WP2B CAS 27470-51-5 结构式 Chemical Structure

产品介绍 Description

Suxibuzone（27470-51-5 86TDZ5WP2B Suxibuzone Suxibuzone [INN:BAN:JAN] Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester (9CI) 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester) Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) AE-17 Alfide BRN 0904563 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate EINECS 248-477-6 Flogos Solurol Suxibuzona [INN-Spanish] Suxibuzonum [INN-Latin] 4-Hydroxymethylbutazolidine hemisuccinate 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure AE 17 Flamilon Danilon Calibene Aflogan Suxibuzona Suxibuzonum UNII-86TDZ5WP2B，CAS 号 27470-51-5）是 CATO 佳途自主生产的药物标准品，分子式 C24H38N2O6，分子量 450.57。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

Suxibuzone的产生途径与其化学式中黄酮骨架，酰胺类，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C24H38N2O6 的Suxibuzone（27470-51-5 86TDZ5WP2B Suxibuzone Suxibuzone INN:BAN:JAN Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester (9CI) 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester) Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrog

应用场景：在化学分析实验室中，Suxibuzone（CAS 27470-51-5）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以Suxibuzone配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于阴凉处（≤25°C）保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影

理化性质 Physical & Chemical Properties

中文名称Suxibuzone
分子式C24H38N2O6
分子量450.57 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）7.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1964年
含氮原子数2

相关专利 Related Patents

  1. 发明人张德明，王建平，李文辉. "一种Suxibuzone的合成方法" [P]. 中国发明专利, 专利号 CN 112996626 A, 授权公告日 2020-11-15.
  2. Anderson J P, Hughes D C, Johnson M A. "Method for the Synthesis of 27470-51-5 86TDZ5WP2B Suxibuzone Suxibuzone [INN:BAN:JAN] Butanedioic acid, mono((4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl) ester (9CI) 4-Butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate (ester) Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) AE-17 Alfide BRN 0904563 4-Butyl-4-(beta-carboxypropionyl-oxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione 4-Butyl-4-hydroxymethyl-1,2-diphenyl-3,5-pyrazolidinedione hydrogen succinate EINECS 248-477-6 Flogos Solurol Suxibuzona [INN-Spanish] Suxibuzonum [INN-Latin] 4-Hydroxymethylbutazolidine hemisuccinate 3-((4-Butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methoxycarbonyl)propionsaeure AE 17 Flamilon Danilon Calibene Aflogan Suxibuzona Suxibuzonum UNII-86TDZ5WP2B" [P]. US Patent, US 9620965 B2, 2021-02-12.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of Suxibuzone in Pharmaceutical Formulations". Food Chem., 2017, 383, (6), 5156-5160.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of Suxibuzone as an Impurity". J. Pharm. Biomed. Anal., 2020, 2435, 6250-6253.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...